Susquehanna International Group, LLP Genmab A/S Transaction History

Susquehanna International Group, LLP

$641 Billion
Q4 2024

A detailed history of Susquehanna International Group, LLP transactions in Genmab A/S stock. As of the latest transaction made, Susquehanna International Group, LLP holds 17,244 shares of GMAB stock, worth $386,955. This represents 0.0% of its overall portfolio holdings.

Number of Shares

17,244

Previous 28,785 40.09%

Holding current value

$386,955

Previous $701,000 48.79%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$20.02 - $24.15 $231,050 - $278,715	-11,541 Reduced 40.09%	17,244 $359,000
Q3 2024 Nov 14, 2024	SELL	$23.84 - $28.48 $475,894 - $568,517	-19,962 Reduced 40.95%	28,785 $701,000
Q2 2024 Aug 15, 2024	BUY	$25.13 - $30.27 $499,056 - $601,131	19,859 Added 68.74%	48,747 $1.23 Million
Q1 2024 May 07, 2024	BUY	$26.43 - $32.77 $335,132 - $415,523	12,680 Added 78.23%	28,888 $864,000
Q4 2023 Feb 14, 2024	BUY	$27.94 - $35.44 $452,851 - $574,411	16,208 New	16,208 $516,000
Q2 2023 Aug 11, 2023	SELL	$37.4 - $42.94 $733,563 - $842,225	-19,614 Reduced 76.14%	6,147 $233,000
Q1 2023 May 16, 2023	SELL	$34.88 - $43.22 $144,961 - $179,622	-4,156 Reduced 13.89%	25,761 $972,000
Q4 2022 Feb 14, 2023	BUY	$33.8 - $47.06 $1.01 Million - $1.41 Million	29,917 New	29,917 $1.27 Million
Q2 2022 Aug 15, 2022	SELL	$26.83 - $38.57 $267,012 - $383,848	-9,952 Reduced 52.6%	8,968 $291,000
Q1 2022 May 16, 2022	SELL	$30.95 - $39.68 $387,401 - $496,674	-12,517 Reduced 39.82%	18,920 $685,000
Q4 2021 Feb 14, 2022	SELL	$35.87 - $47.12 $1.05 Million - $1.38 Million	-29,309 Reduced 48.25%	31,437 $1.24 Million
Q3 2021 Nov 15, 2021	BUY	$41.55 - $48.72 $2.13 Million - $2.5 Million	51,220 Added 537.69%	60,746 $2.66 Million
Q2 2021 Aug 11, 2021	SELL	$32.88 - $44.57 $1.83 Million - $2.48 Million	-55,596 Reduced 85.37%	9,526 $389,000
Q1 2021 May 17, 2021	BUY	$30.92 - $44.4 $152,652 - $219,202	4,937 Added 8.2%	65,122 $2.14 Million
Q4 2020 Feb 16, 2021	SELL	$33.66 - $40.76 $257,297 - $311,569	-7,644 Reduced 11.27%	60,185 $2.45 Million
Q3 2020 Nov 16, 2020	BUY	$33.07 - $38.68 $654,819 - $765,902	19,801 Added 41.23%	67,829 $2.48 Million
Q2 2020 Aug 14, 2020	BUY	$20.05 - $33.89 $771,644 - $1.3 Million	38,486 Added 403.33%	48,028 $1.63 Million
Q1 2020 May 15, 2020	SELL	$17.15 - $25.22 $15,006 - $22,067	-875 Reduced 8.4%	9,542 $202,000
Q4 2019 Feb 14, 2020	BUY	$18.88 - $24.14 $196,672 - $251,466	10,417 New	10,417 $233,000

Others Institutions Holding GMAB

# of Institutions

246

Shares Held

61.3M

Call Options Held

159K

Put Options Held

38K

View Full List

About GENMAB A/S

Ticker GMAB
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 658,292,992
Market Cap $14.8B
Description
Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...

More about GMAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP Genmab A/S Transaction History